Study Design and Interim Outcomes of Guangzhou Institute of Respiratory Disease COPD Biobank.
PubWeight™: 0.76‹?›
Published in COPD on December 01, 2015
Authors
Wenju Lu1,2, Zeguang Zheng1, Xindong Chen3, Hui Tan4, Jian Wang1, Zili Zhang1, Jinping Zheng1, Rongchang Chen1, Chenting Zhang1, Xiaoming Xu1, Yuqin Chen1, Quan Yang1, Mingmei Xiong1, Meihua Guo1, Qipeng Zhou1, Chun Tang1, Yingfeng Wang1, Jinmei Ye1, Defu Li1, Jiaze Shu1, Shu Tan1, Chuyi Xu1, Yan Wang1,5, Ning Lai1, Kai Yang1, Jiachun Lu1,5, Pixin Ran1, Nanshan Zhong1
Author Affiliations
1: a State Key Laboratory of Respiratory Diseases, Guangzhou Institute of Respiratory Disease, The First Affiliated Hospital, Guangzhou Medical University , Guangzhou , Guangdong , China.
2: b Department of Laboratory Medicine, The First Affiliated Hospital, Guangzhou Medical University , Guangzhou , Guangdong , China.
3: c Department of Respiratory Medicine, The First Municipal Hospital of Lufeng , Lufeng , Guangdong , China.
4: d Department of Respiratory Medicine, The First Municipal Hospital of Chenzhou , Chenzhou , Hunan , China.
5: e The Institute for Chemical Carcinogenesis, Guangzhou Medical University , Guangzhou , Guangdong , China.